163 related articles for article (PubMed ID: 20828645)
21. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
22. [Duration of the effect and dose-response relationship of ridazolol in patients with coronary heart disease].
Fach WA; Starke E; Becker HJ
Z Kardiol; 1992 Jun; 81(6):320-5. PubMed ID: 1353933
[TBL] [Abstract][Full Text] [Related]
23. Ranolazine: a new option in the management of chronic stable angina.
Dobesh PP; Trujillo TC
Pharmacotherapy; 2007 Dec; 27(12):1659-76. PubMed ID: 18041887
[TBL] [Abstract][Full Text] [Related]
24. Comparison of myocardial ischemia on the ergocycle versus the treadmill in patients with coronary heart disease.
Noël M; Jobin J; Marcoux A; Poirier P; Dagenais G; Bogaty P
Am J Cardiol; 2010 Mar; 105(5):633-9. PubMed ID: 20185009
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
Chaitman BR
J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
[TBL] [Abstract][Full Text] [Related]
26. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
Edwards RJ; Redwood SR; Lambiase PD; Marber MS
Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
[TBL] [Abstract][Full Text] [Related]
27. Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests.
Jneid H; Chandra M; Alshaher M; Hornung CA; Tang XL; Leesar M; Bolli R
Circulation; 2005 May; 111(20):2565-71. PubMed ID: 15897341
[TBL] [Abstract][Full Text] [Related]
28. Detrimental effects of acute heparin administration on ischemic threshold in patients with coronary artery disease.
Fragasso G; Leonardo F; Piatti P; Monti LD; Sheiban I; Gernone F; Setola E; Pontiroli AE; Chierchia SL
Ital Heart J; 2000 Jun; 1(6):407-11. PubMed ID: 10929741
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Wilson SR; Scirica BM; Braunwald E; Murphy SA; Karwatowska-Prokopczuk E; Buros JL; Chaitman BR; Morrow DA
J Am Coll Cardiol; 2009 Apr; 53(17):1510-6. PubMed ID: 19389561
[TBL] [Abstract][Full Text] [Related]
30. Exercise-induced ST-segment depression: imbalance between myocardial oxygen demand and myocardial blood flow.
Watanabe T; Akutsu Y; Yamanaka H; Michihata T; Okazaki O; Katagiri T; Harumi K
Acta Cardiol; 2000 Feb; 55(1):25-31. PubMed ID: 10707755
[TBL] [Abstract][Full Text] [Related]
31. A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group.
Pepine CJ; Wolff AA
Am J Cardiol; 1999 Jul; 84(1):46-50. PubMed ID: 10404850
[TBL] [Abstract][Full Text] [Related]
32. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
Villano A; Di Franco A; Nerla R; Sestito A; Tarzia P; Lamendola P; Di Monaco A; Sarullo FM; Lanza GA; Crea F
Am J Cardiol; 2013 Jul; 112(1):8-13. PubMed ID: 23558043
[TBL] [Abstract][Full Text] [Related]
33. Different thresholds of myocardial ischemia in ramp and standard bruce protocol exercise tests in patients with positive exercise stress tests and angiographically demonstrated coronary arterial narrowing.
Noël M; Jobin J; Poirier P; Dagenais GR; Bogaty P
Am J Cardiol; 2007 Apr; 99(7):921-4. PubMed ID: 17398184
[TBL] [Abstract][Full Text] [Related]
34. Clinical experience with ranolazine in a veteran population with chronic stable angina.
Reeder DN; Gillette MA; Franck AJ; Frohnapple DJ
Ann Pharmacother; 2012 Jan; 46(1):42-50. PubMed ID: 22215689
[TBL] [Abstract][Full Text] [Related]
35. A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina.
Chaitman BR; Ho AP; Behm MO; Rowe JF; Palcza JS; Laethem T; Heirman I; Panebianco DL; Kobalava Z; Martsevich SY; Free AL; Bittar N; Chrysant SG; Ho TW; Chodakewitz JA; Murphy MG; Blanchard RL
Clin Pharmacol Ther; 2012 Mar; 91(3):459-66. PubMed ID: 22278333
[TBL] [Abstract][Full Text] [Related]
36. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
Thadani U
Expert Opin Pharmacother; 2012 Dec; 13(17):2555-63. PubMed ID: 23121448
[TBL] [Abstract][Full Text] [Related]
37. Effects of ranolazine on various outcomes in patients with stable angina: an updated meta-analysis.
Manolis A; Kallistratos M; Poulimenos L; Zamfir T; Thomopoulos C
Hellenic J Cardiol; 2023; 71():26-32. PubMed ID: 36481415
[TBL] [Abstract][Full Text] [Related]
38. Effects of intravenous theophylline on exercise-induced myocardial ischemia. I. Impact on the ischemic threshold.
Heller GV; Barbour MM; Dweik RB; Corning JJ; McClellan JR; Garber CE
J Am Coll Cardiol; 1993 Apr; 21(5):1075-9. PubMed ID: 8459060
[TBL] [Abstract][Full Text] [Related]
39. Effect of ranolazine on infarct size in a canine model of regional myocardial ischemia/reperfusion.
Black SC; Gralinski MR; McCormack JG; Driscoll EM; Lucchesi BR
J Cardiovasc Pharmacol; 1994 Dec; 24(6):921-8. PubMed ID: 7898075
[TBL] [Abstract][Full Text] [Related]
40. Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia.
Castro RR; Porphirio G; Serra SM; Nóbrega AC
Heart; 2004 Oct; 90(10):1119-23. PubMed ID: 15367503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
